This is a preview of subscription content, log in via an institution to check access.
Notes
National Health Service
Reference
NICE. Inotersen for treating hereditary transthyretin-related amyloidosis Internet Document : 16 Apr 2019. Available from: URL: https://www.nice.org.uk/guidance/gid-hst10013/documents/final-evaluation-determination-document
Rights and permissions
About this article
Cite this article
NICE recommends inotersen for transthyretin-related amyloidosis. PharmacoEcon Outcomes News 827, 35 (2019). https://doi.org/10.1007/s40274-019-5873-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5873-y